SBIR/STTR Research Award

Self-assembled Dual-functionality Microspheres

Award identifier 7d7811ae615ebf137b4bf855b3bcb3d01626a172491beee34cb6e193c7ea2f0fAwarding agency National Aeronautics and Space Administration

Award amount

$68,668

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Aeronautics and Space Administration
Branch
Not reported
Recipient company
SBA Materials Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The proposed objective is to develop a nanostructured self-assembled biomedical device whose function is mediated by device design at molecular, meso- and micron scale levels. The dominant innovation is a rapid ?single-pot? microsphere self-assembly process that features biomolecule-nanoparticle attachment. Syntheses of distinct nanoparticles functionalized with different organic moieties provide means for nanoparticle-biomolecular interac-tions not previously possible, first for amplified, localized specific therapeutic delivery, second for specific cell population targeting. These functionalized hybrid moieties are cooperatively assembled into hollow microspherical units in a highly controllable process, resulting in dual-function high therapeutic capacity delivery vehicles using biomolecular recognition principles. A therapeutic agent resides on an array of functionalized nanoparticles on the interior of hollow microspheres, while an antibody or short peptide is selectively assembled on nanoparticles on the microsphere?s exterior, permitting loading of therapeutic molecules and delivery. Based on principles of hierarchi-cal self-assembly, this system?s advantages include: 1) biocompatible reagents, 2) compatability with aqueous environments, 3) functionalized nanoparticle variety permitting multifunctional device delivery systems, 4) surface-attached proteins to provide a steering mechanism, and finally, 5) an ion-based opening mechanism, consequently amplifying targeted therapeutic treatment. These innovations enhance therapeutic agent delivery and molecular imaging in numerous medical applications, including those in space.

Technology keywords

Not reported

Agency intelligence

National Aeronautics and Space Administration

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.